173 related articles for article (PubMed ID: 29181105)
1. Overexpression of long non-coding RNA colon cancer-associated transcript 2 is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
Zhang J; Jiang Y; Zhu J; Wu T; Ma J; Du C; Chen S; Li T; Han J; Wang X
Oncol Lett; 2017 Dec; 14(6):6907-6914. PubMed ID: 29181105
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma.
Fu C; Xu X; Lu W; Nie L; Yin T; Wu D
Medicine (Baltimore); 2019 Oct; 98(42):e17412. PubMed ID: 31626095
[TBL] [Abstract][Full Text] [Related]
5. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
6. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer.
Wang L; Duan W; Yan S; Xie Y; Wang C
Biomed Pharmacother; 2019 May; 113():108758. PubMed ID: 30877883
[TBL] [Abstract][Full Text] [Related]
7. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling.
Chen B; Dragomir MP; Fabris L; Bayraktar R; Knutsen E; Liu X; Tang C; Li Y; Shimura T; Ivkovic TC; De Los Santos MC; Anfossi S; Shimizu M; Shah MY; Ling H; Shen P; Multani AS; Pardini B; Burks JK; Katayama H; Reineke LC; Huo L; Syed M; Song S; Ferracin M; Oki E; Fromm B; Ivan C; Bhuvaneshwar K; Gusev Y; Mimori K; Menter D; Sen S; Matsuyama T; Uetake H; Vasilescu C; Kopetz S; Parker-Thornburg J; Taguchi A; Hanash SM; Girnita L; Slaby O; Goel A; Varani G; Gagea M; Li C; Ajani JA; Calin GA
Gastroenterology; 2020 Dec; 159(6):2146-2162.e33. PubMed ID: 32805281
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA CCAT2 Activates RAB14 and Acts as an Oncogene in Colorectal Cancer.
Wang D; Li Z; Yin H
Front Oncol; 2021; 11():751903. PubMed ID: 34868956
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition.
Xu Y; Wang B; Zhang F; Wang A; Du X; Hu P; Zhu Y; Fang Z
Onco Targets Ther; 2017; 10():1191-1198. PubMed ID: 28280353
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CCAT2 promotes proliferation and suppresses apoptosis of colorectal cancer cells.
Gao P; Sun D; Guo H; Wu Z; Chen J
J BUON; 2020; 25(4):1840-1846. PubMed ID: 33099922
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of long non‑coding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma.
Bai JG; Tang RF; Shang JF; Qi S; Yu GD; Sun C
Mol Med Rep; 2018 Apr; 17(4):5328-5335. PubMed ID: 29393466
[TBL] [Abstract][Full Text] [Related]
12. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH
Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
[TBL] [Abstract][Full Text] [Related]
13. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
Shen X; Bai Y; Luo B; Zhou X
Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
[TBL] [Abstract][Full Text] [Related]
16. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer.
Ozawa T; Matsuyama T; Toiyama Y; Takahashi N; Ishikawa T; Uetake H; Yamada Y; Kusunoki M; Calin G; Goel A
Ann Oncol; 2017 Aug; 28(8):1882-1888. PubMed ID: 28838211
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
Ruan R; Zhao XL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
Liu Y; Zhang M; Liang L; Li J; Chen YX
Int J Clin Exp Pathol; 2015; 8(9):11480-4. PubMed ID: 26617879
[TBL] [Abstract][Full Text] [Related]
19. Expression of lncRNA CCAT2 in children with neuroblastoma and its effect on cancer cell growth.
Chen M; Zhao M; Hou Y; Zhu B
Mol Cell Biochem; 2021 Apr; 476(4):1871-1879. PubMed ID: 33475889
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer.
Chen S; Wu H; Lv N; Wang H; Wang Y; Tang Q; Shao H; Sun C
Biomed Pharmacother; 2016 Aug; 82():583-8. PubMed ID: 27470400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
